The article highlights the severe and ongoing decline of the horseracing industry in the Americas, particularly criticizing the flawed claiming system introduced in 1993. This system has failed to generate adequate profits or sustain economic viability, leading to dwindling race numbers, breeding rates, and stagnant customer bases in countries like the USA, Canada, and Jamaica. Despite substantial revenues, companies like Supreme Ventures Racing & Entertainment Limited (SVREL) report significant net losses, underscoring the unsustainable business model and lack of effective management expertise in promoting the sport.

Comparatively, horseracing markets in smaller countries such as Japan, Hong Kong, and South Korea continue to grow robustly, highlighting the stark contrast with the North American decline. The article also touches on regulatory debates in the US, such as the controversy over the use of Lasix, a drug used to treat exercise-induced bleeding in horses. Overall, the piece warns that without immediate and fundamental changes, including reconsidering the current racing product and management approach, the future of horseracing on this side of the Atlantic is bleak, with potential extinction looming.